Explore

Trendline Trendline
Collaborative Drug Discovery Partners with Eli Lilly to Enhance Biotech Innovation

Collaborative Drug Discovery Partners with Eli Lilly to Enhance Biotech Innovation

Collaborative Drug Discovery Partners with Eli Lilly to Enhance Biotech Innovation
Trendline Trendline
Eli Lilly, Bristol Myers Squibb, and Incyte Advance AI Integration in Drug Development

Eli Lilly, Bristol Myers Squibb, and Incyte Advance AI Integration in Drug Development

Eli Lilly, Bristol Myers Squibb, and Incyte Advance AI Integration in Drug Development
Trendline Trendline
OpenBind Launches AI Model for Drug Discovery with Extensive Dataset

OpenBind Launches AI Model for Drug Discovery with Extensive Dataset

OpenBind Launches AI Model for Drug Discovery with Extensive Dataset
Trendline Trendline
Eli Lilly Acquires Engage Bio for $202 Million to Enhance Genetic Medicines Portfolio

Eli Lilly Acquires Engage Bio for $202 Million to Enhance Genetic Medicines Portfolio

Eli Lilly Acquires Engage Bio for $202 Million to Enhance Genetic Medicines Portfolio
Trendline Trendline
OpenBind Introduces AI Model to Revolutionize Drug Discovery

OpenBind Introduces AI Model to Revolutionize Drug Discovery

OpenBind Introduces AI Model to Revolutionize Drug Discovery
Trendline Trendline
Incyte and Edison Scientific Collaborate to Enhance Drug Development with AI

Incyte and Edison Scientific Collaborate to Enhance Drug Development with AI

Incyte and Edison Scientific Collaborate to Enhance Drug Development with AI
Trendline Trendline
OpenBind Launches AI Model to Revolutionize Drug Discovery with Large-Scale Data

OpenBind Launches AI Model to Revolutionize Drug Discovery with Large-Scale Data

OpenBind Launches AI Model to Revolutionize Drug Discovery with Large-Scale Data
Trendline Trendline
FUJIFILM Cellular Dynamics Opens New iPSC Facility in Madison, Expanding U.S. Manufacturing

FUJIFILM Cellular Dynamics Opens New iPSC Facility in Madison, Expanding U.S. Manufacturing

FUJIFILM Cellular Dynamics Opens New iPSC Facility in Madison, Expanding U.S. Manufacturing
Trendline Trendline
InSphero AG Acquires PhenoVista Biosciences to Enhance 3D Cell-based Assay Capabilities

InSphero AG Acquires PhenoVista Biosciences to Enhance 3D Cell-based Assay Capabilities

InSphero AG Acquires PhenoVista Biosciences to Enhance 3D Cell-based Assay Capabilities
Trendline Trendline
Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform

Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform

Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform
Trendline Trendline
Regeneron and Parabilis Collaborate to Develop New Drug Class Targeting Undruggable Proteins

Regeneron and Parabilis Collaborate to Develop New Drug Class Targeting Undruggable Proteins

Regeneron and Parabilis Collaborate to Develop New Drug Class Targeting Undruggable Proteins
Trendline Trendline
AI in Biotechnology: Transforming Drug Discovery and Personalized Medicine

AI in Biotechnology: Transforming Drug Discovery and Personalized Medicine

AI in Biotechnology: Transforming Drug Discovery and Personalized Medicine